Publicacións en colaboración con investigadores/as de KU Leuven (35)

2024

  1. Risks and benefits of sharing patient information on social media: a digital dilemma

    European Heart Journal - Digital Health, Vol. 5, Núm. 3, pp. 199-207

2023

  1. Donor heart selection: Evidence-based guidelines for providers

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 1, pp. 7-29

  2. How does age affect outcomes after left ventricular assist device implantation: results from the PCHF-VAD registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 884-894

  3. Sex-related differences in left ventricular assist device utilization and outcomes: results from the PCHF-VAD registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1054-1065

2022

  1. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

  2. Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation

    Heart and Vessels, Vol. 37, Núm. 12, pp. 1985-1994

  3. Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1305-1315

  4. Is degree of chronic illness management in heart transplant centers associated with better patient survival? Findings from the intercontinental BRIGHT study

    Chronic Illness, Vol. 18, Núm. 4, pp. 806-817

  5. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry

    Heart Rhythm, Vol. 19, Núm. 2, pp. 228-234

  6. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience

    European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 899-907

2021

  1. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

    Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662

  2. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

  3. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4955-4967

  4. Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker

    Journal of Cardiovascular Electrophysiology, Vol. 32, Núm. 3, pp. 832-841

  5. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2020

  1. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

    European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392

  2. Validation of the patient assessment of chronic illness care (PACIC) short form scale in heart transplant recipients: The international cross-sectional bright study

    BMC Health Services Research, Vol. 20, Núm. 1

2019

  1. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry

    European Journal of Heart Failure, Vol. 21, Núm. 9, pp. 1129-1141

  2. Inter-vendor reproducibility and accuracy of segmental left ventricular strain measurements using CMR feature tracking

    European Radiology, Vol. 29, Núm. 12, pp. 6846-6857

  3. Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

    Clinical Therapeutics, Vol. 41, Núm. 1, pp. 130-136